2 FTSE stocks that could do well with the DeepSeek AI breakthrough

Jon Smith talks through the implications of the latest AI news and flags up some FTSE shares that could benefit from the progress as a result.

| More on:
artificial intelligence investing algorithms

Image source: Getty Images.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One of the hottest stories from the week has been the DeepSeek AI model and its implications for the sector. Yet while most of the focus has been on AI stocks, other businesses, from other areas of the economy may be impacted. Here are a couple of FTSE shares that investors could consider that stand to gain from the latest news.

Capex spending in focus

One takeaway from the news is that AI models can be built for a fraction of the cost that many thought. DeepSeek reportedly only cost $6m to train. This angle could help to benefit BT Group (LSE:BT.A). The growth stock is up 21% over the past year.

BT Group has huge potential to integrate AI into its existing system. It has recently focused on pouring money into the nationwide full fibre rollout. This is now past peak capital expense (capex) spending, with the latest H1 results stating that “our cost to build continues to reduce, enabling us to increase this year’s build target to 4.2 million with no additional capex spend”.

Going forward, this could free up cash flow and other resources to be directed towards AI. By implementing advanced AI-driven tools, BT could optimize bandwidth allocation, predict faults, and improve overall user experiences, especially in its fibre and 5G networks. It could use the advanced AI models to help with cutting-edge cybersecurity solutions. This would allow it to protect its infrastructure and offer enhanced services to enterprise clients.

The fact that models can be built cheaper than expected means that these projects could now be well in scope and in budget. The gains from implementing could ultimately help to reduce costs and make the business more profitable.

However, regulatory risk is something to be aware of. BT is heavily regulated and so changing price caps and policy shifts from the government can impact the firm.

A sector ripe for change

Another business that could do well is AstraZeneca (LSE:AZN). The FTSE 100 company is already spending large amounts on AI developement. The key areas being targeted are in drug discovery and data analysis. In my view, it hasn’t scratched the surface of the enhancements and efficiencies that could be gained from AI.

For example, the research and developement (R&D) process is still quite manual. Making greater use of AI in this area to take out some human tasks not only reduces the potential for error but reduces costs in the long run. The breakthrough with DeepSeek could mean that more R&D funds get allocated to running more complex AI models, given that the cost isn’t as high as previously thought. With more models popping up, it could even encourage AstraZeneca to announce a partnership around building bespoke models for the pharmaseuctical sector.

Investors need to be careful as this is a very competitive industry. This is a risk going forward, as market share can quickly get eaten away.

The stock is up 6% over the last year. Yet it could stand to rally significantly if it really embraces AI going forward. Given the potential for this sector to benefit from the integration, I think the share price could do well. I believe both stocks are worthy of consideration for an investor.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jon Smith has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Growth Shares

Investing Articles

The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Is it worth me buying Lloyds shares for 61p after a 49% rise?

Lloyds shares have risen significantly from their one-year traded low seen last February, which could mean no value is left…

Read more »

Investing Articles

I think this FTSE 100 fashion stock could skyrocket in 2025

JD Sports has had a disastrous few months of losses but 2025 looks primed to be the year for this…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

At £26.46 Shell’s share price is down 10% from its 12-month traded high, so should I buy more now?

Shell is looking to close the longstanding valuation gap between its share price and its peers by aggressively targeting more…

Read more »

Investing Articles

I’ve got a queasy feeling about the Diageo share price

The Diageo share price has been hit by one piece of bad news after another, and Harvey Jones is finding…

Read more »

Investing Articles

With major new agreements now signed, does BAE Systems’ share price look an unmissable bargain to me at £12.08?

I think BAE Systems’ share price is down on the false assumption that the global security threat will fall in…

Read more »

Investing Articles

Here are the latest growth forecasts for Greggs shares to 2026!

Greggs shares have tanked at the beginning of 2025! Does this represent an attractive dip buying opportunity for growth investors?

Read more »

Investing Articles

Up 68%! Here’s 1 FTSE 100 high-flyer with an eye on the future

The FTSE 100 isn't renowned for its growth stocks, but following a 68% climb, this might be one for investors…

Read more »